(UroToday.com) Dr. Christian Arson of Düsseldorf Germany presents on the PROBASE trial, a risk-adapted screening study for prostate cancer based on age and baseline PSA alone. This is a preliminary presentation of early results for an ongoing study.
(UroToday.com) Dr. Christian Arson of Düsseldorf Germany presents on the PROBASE trial, a risk-adapted screening study for prostate cancer based on age and baseline PSA alone. This is a preliminary presentation of early results for an ongoing study.